Cargando…

Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?

BACKGROUND: We aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. METHODS: The present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Zeinab, Baradaran, Hamid Reza, Kohansal, Karim, Hadaegh, Farzad, Azizi, Fereidoun, Khalili, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585180/
https://www.ncbi.nlm.nih.gov/pubmed/36277718
http://dx.doi.org/10.3389/fendo.2022.1041808
_version_ 1784813433254838272
author Alizadeh, Zeinab
Baradaran, Hamid Reza
Kohansal, Karim
Hadaegh, Farzad
Azizi, Fereidoun
Khalili, Davood
author_facet Alizadeh, Zeinab
Baradaran, Hamid Reza
Kohansal, Karim
Hadaegh, Farzad
Azizi, Fereidoun
Khalili, Davood
author_sort Alizadeh, Zeinab
collection PubMed
description BACKGROUND: We aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. METHODS: The present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of the Tehran Lipid and Glucose Study, with a 10-year follow-up. Glycemic status at follow-up was categorized as regression to normoglycemia: fasting plasma glucose [FPG] of <5.55 and 2h-plasma glucose [PG] of <7.77 mmol/L, and not taking antidiabetic medications. Glycemic status at follow-up was categorized as progression to diabetes: FPG ≥7 or 2h-PG of ≥11.1 mmol/L, or taking antidiabetic medications. Glycemic status determined whether the patients remained in prediabetes category (isolated impaired fasting glycaemia [iIFG] [(5.55≤FPG<7 and 2h-PG<7.77 mmol/L); isolated impared glucose tolarence [iIGT] (7.77 ≤ 2h-PG<11.1 and FGP<5.55 mmol/L)]. With prediabetes as a reference, multinomial logistic regression was utilized to identify the determinants of glycemic changes. RESULTS: Approximately 40% of participants returned to normoglycemia (n = 578), and similar percentage of participants progressed to diabetes (n = 518). Based on the multivariable multinomial model, regression to normoglycemia was associated with age (relative risk ratio [RRR] = 0.97; 95% CI, 0.95-0.99), female sex (RRR = 1.72; 95% CI, 1.18-2.50), high education level of ≥12 years (RRR = 2.10; 95% CI, 1.19-3.70), and combined IFG/impaired glucose tolerance (IGT) versus IFG (RRR = 0.45; 95% CI, 0.29-0.70). The risk of progression to diabetes increased with body mass index (RRR = 1.10; 95% CI, 1.05-1.15), waist circumference (RRR = 0.97; 95% CI, 0.96-0.99), positive familial history of diabetes (RRR = 1.62; 95% CI, 1.07-2.45), and combined IFG/IGT versus IFG (RRR = 2.54; 95% CI, 1.71-3.77). CONCLUSION: A small percentage of patients with prediabetes remain in this condition, but the majority go on to develop diabetes or regress to normoglycemia. Both directions had distinct predictors.
format Online
Article
Text
id pubmed-9585180
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95851802022-10-22 Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? Alizadeh, Zeinab Baradaran, Hamid Reza Kohansal, Karim Hadaegh, Farzad Azizi, Fereidoun Khalili, Davood Front Endocrinol (Lausanne) Endocrinology BACKGROUND: We aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. METHODS: The present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of the Tehran Lipid and Glucose Study, with a 10-year follow-up. Glycemic status at follow-up was categorized as regression to normoglycemia: fasting plasma glucose [FPG] of <5.55 and 2h-plasma glucose [PG] of <7.77 mmol/L, and not taking antidiabetic medications. Glycemic status at follow-up was categorized as progression to diabetes: FPG ≥7 or 2h-PG of ≥11.1 mmol/L, or taking antidiabetic medications. Glycemic status determined whether the patients remained in prediabetes category (isolated impaired fasting glycaemia [iIFG] [(5.55≤FPG<7 and 2h-PG<7.77 mmol/L); isolated impared glucose tolarence [iIGT] (7.77 ≤ 2h-PG<11.1 and FGP<5.55 mmol/L)]. With prediabetes as a reference, multinomial logistic regression was utilized to identify the determinants of glycemic changes. RESULTS: Approximately 40% of participants returned to normoglycemia (n = 578), and similar percentage of participants progressed to diabetes (n = 518). Based on the multivariable multinomial model, regression to normoglycemia was associated with age (relative risk ratio [RRR] = 0.97; 95% CI, 0.95-0.99), female sex (RRR = 1.72; 95% CI, 1.18-2.50), high education level of ≥12 years (RRR = 2.10; 95% CI, 1.19-3.70), and combined IFG/impaired glucose tolerance (IGT) versus IFG (RRR = 0.45; 95% CI, 0.29-0.70). The risk of progression to diabetes increased with body mass index (RRR = 1.10; 95% CI, 1.05-1.15), waist circumference (RRR = 0.97; 95% CI, 0.96-0.99), positive familial history of diabetes (RRR = 1.62; 95% CI, 1.07-2.45), and combined IFG/IGT versus IFG (RRR = 2.54; 95% CI, 1.71-3.77). CONCLUSION: A small percentage of patients with prediabetes remain in this condition, but the majority go on to develop diabetes or regress to normoglycemia. Both directions had distinct predictors. Frontiers Media S.A. 2022-10-07 /pmc/articles/PMC9585180/ /pubmed/36277718 http://dx.doi.org/10.3389/fendo.2022.1041808 Text en Copyright © 2022 Alizadeh, Baradaran, Kohansal, Hadaegh, Azizi and Khalili https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Alizadeh, Zeinab
Baradaran, Hamid Reza
Kohansal, Karim
Hadaegh, Farzad
Azizi, Fereidoun
Khalili, Davood
Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
title Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
title_full Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
title_fullStr Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
title_full_unstemmed Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
title_short Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
title_sort are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585180/
https://www.ncbi.nlm.nih.gov/pubmed/36277718
http://dx.doi.org/10.3389/fendo.2022.1041808
work_keys_str_mv AT alizadehzeinab arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame
AT baradaranhamidreza arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame
AT kohansalkarim arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame
AT hadaeghfarzad arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame
AT azizifereidoun arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame
AT khalilidavood arethedeterminantsoftheprogressiontotype2diabetesandregressiontonormoglycemiainthepopulationswithprediabetesthesame